Innate Pharma S.A - Stock Price History | IPHA
Historical daily share price chart and data for Innate Pharma S.A since 2021 adjusted for splits. The latest closing stock price for Innate Pharma S.A as of September 24, 2021 is 6.70.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Innate Pharma S.A stock closing price was 8.20 on May 11, 2020.
- The Innate Pharma S.A 52-week high stock price is 11.95, which is 78.4% above the current share price.
- The Innate Pharma S.A 52-week low stock price is 3.02, which is 54.9% below the current share price.
- The average Innate Pharma S.A stock price for the last 52 weeks is 4.26.
|Innate Pharma S.A Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.